Literature DB >> 8656657

Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium.

Y Kihara1, M Inoko, N Hatakeyama, Y Momose, S Sasayama.   

Abstract

We studied the subcellular mechanisms responsible for the negative inotropic effects of the two Ic drugs flecainide and pilsicainide. Aequorin luminescence (Ca2+i) and isometric tension were recorded simultaneously in isolated trabeculae from the dog ventricle. In isolated myocytes from the same ventricle, the slow inward current (ICa) was recorded. Both flecainide and pilsicainide decreased peak Ca2+i, peak tension, and peak ICa concentration dependently. Each effect with flecainide was more marked than that with pilsicainide; however, Ca2+i and ICa paralleled each other in changes in tension, and the tension-Ca2+i-ICa relationship showed the same curve for each drug. We conclude that the difference in negative inotropic effects of these class Ic drugs are primarily related to their effects on L-type Ca2+ channels and the subsequent decreases in the amount of Ca2+ released from the sarcoplasmic reticulum (SR) during each cardiac cycle. Therefore, their negative inotropic effects may not be directly correlated with the essential mechanisms responsible for their antiarrhythmic action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8656657     DOI: 10.1097/00005344-199601000-00008

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations.

Authors:  A Sugiyama; S Takehana; R Kimura; K Hashimoto
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors:  Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

4.  Mapping ventricular fibrillation: a simplified experimental model leads to a complicated result.

Authors:  Derek J Dosdall
Journal:  Heart Rhythm       Date:  2009-02-05       Impact factor: 6.343

Review 5.  Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.

Authors:  Samantha C Salvage; Karthik H Chandrasekharan; Kamalan Jeevaratnam; Angela F Dulhunty; Andrew J Thompson; Antony P Jackson; Christopher L-H Huang
Journal:  Br J Pharmacol       Date:  2017-05-12       Impact factor: 8.739

6.  Inhibitory effects of class I antiarrhythmic agents on Na+ and Ca2+ currents of human iPS cell-derived cardiomyocytes.

Authors:  Sayaka Yonemizu; Keiichiro Masuda; Yasutaka Kurata; Tomomi Notsu; Yuhei Higashi; Kenta Fukumura; Peili Li; Haruaki Ninomiya; Junichiro Miake; Motokazu Tsuneto; Yasuaki Shirayoshi; Ichiro Hisatome
Journal:  Regen Ther       Date:  2019-02-01       Impact factor: 3.419

7.  The cardiac work-loop technique: An in vitro model for identifying and profiling drug-induced changes in inotropy using rat papillary muscles.

Authors:  Sophie Fletcher; Helen Maddock; Rob S James; Rob Wallis; Mayel Gharanei
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379

8.  Mechanisms of flecainide induced negative inotropy: An in silico study.

Authors:  Pei-Chi Yang; Wayne R Giles; Luiz Belardinelli; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2021-05-15       Impact factor: 5.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.